Inflammation is a recognised hallmark of cancer that substantially contributes to the development
and progression of malignancies. In established cancers, there is increasing evidence …

There is increasing and consistent evidence that cancer-associated inflammation is a key
determinant of outcome in patients with cancer. Various markers of inflammation have been …

Patients with cancer are at particularly high risk for malnutrition because both the disease
and its treatments threaten their nutritional status. Yet cancer-related nutritional risk is …

Since the initial work, a decade ago that the combination of C-reactive protein and albumin,
the Glasgow Prognostic Score (GPS), had independent prognostic value in patients with …

… 10 McMillan DC: An inflammation-based prognostic score and its role in the nutrition-based …
22 Roxburgh CSD, Salmond JM, Horgan PG, Oien KA, McMillan DC: Comparison of the …

… 3•• McMillan DC. An inflammation-based prognostic score and its role in the nutrition-based …
9 Jamieson NB, Glen P, McMillan DC, et al. Systemic inflammatory response predicts …

A score based on the combination of the systemic inflammatory response and albumin hazards
ratio (HR) 1.70, 95% CI 1.23–2.35, P= 0.001) was comparable in prognostic value to that …

INTRODUCTION: Components of the systemic inflammatory response, combined to form
inflammation-based prognostic scores (modified Glasgow Prognostic Score (mGPS), …

Background The impact of anastomotic leakage on immediate postoperative mortality in
patients undergoing potentially curative resection for colorectal cancer is well recognized. Its …

Background Some studies have shown that the presence of a systemic inflammatory response,
as evidenced by raised circulating concentrations of C-reactive protein (CRP), predicted …